Company: SMNR
Filing Date: 2025-04-01
Form Type: NT 10-K
Source: 0001213900-25-026468
Chunk: 1

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-01
Form: NT 10-K
Chunk 1
---
 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
|   | -c | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.                                                                                                                                                                                                                                                                                                                                                                 |

<div align='center'>PART III

NARRATIVE</div>

State below in reasonable detail why Forms 10-K,
20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Denali Capital Acquisition Corp. (the “Company”)
is unable to file its Annual Report on Form 10-K for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission
within the prescribed time period for such filing without unreasonable effort or expense because the Company is in the process of preparing
the financial statements for the year ended December 31, 2024 and will need additional time to complete such financial statements. The
Company expects to file its Annual Report on Form 10-K within fifteen calendar days of the prescribed due date.

<div align='center'>PART IV

OTHER INFORMATION</div>

| (1) | Name and telephone number of person to contact in regard to this notification |

| Lei Huang |     |       -646 |     | 978-5180          |
| (Name)    |     | -Area Code |     | -Telephone Number |

| (2) | Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes ☒ No ☐ |

| (3) | Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ☐ No ☒ |

If so, attach an explanation of the anticipated
change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be
made has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized